首页> 美国卫生研究院文献>California Medicine >HEMOLYTIC ANEMIAS Recent Advances in Diagnosis and Treatment
【2h】

HEMOLYTIC ANEMIAS Recent Advances in Diagnosis and Treatment

机译:溶血性贫血诊断和治疗的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The hemolytic anemias of unknown cause can be separated into two main groups: (1) those produced by a defect in cell structure, which is usually hereditary, and (2) those due to a hemolysin of immune-body type.The hemolytic anemias associated with hypersensitivity to drugs and disease processes such as leukemia are less well understood and need further investigation.Splenectomy is the only effective treatment in congenital hemolytic jaundice and in acquired hemolytic anemia; the operation should be carried out promptly in most cases. Transfusion may be used in all varieties of hemolytic disease and is the only effective form of therapy in sickle-cell anemia and paroxysmal nocturnal hemoglobinuria.
机译:未知原因的溶血性贫血可分为两大类:(1)因细胞结构缺陷而引起的溶血性贫血,通常是遗传性的;(2)由于免疫体类型的溶血素引起的溶血性贫血。脾切除术是对先天性溶血性黄疸和后天性溶血性贫血唯一有效的治疗方法;对白血病和诸如白血病等疾病的超敏反应尚待进一步研究。在大多数情况下,应立即进行操作。输血可用于所有类型的溶血性疾病,并且是镰状细胞性贫血和阵发性夜间血红蛋白尿的唯一有效治疗形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号